Suominen is a manufacturing company. The company manufactures and develops a wide range of wipes, hygiene products and medical applications. The manufacturing is based on non-woven fabrics that can be used for various purposes. Customers are found in several industries, with the largest operations in Europe and North America. The company has its headquarters in Helsinki.
Suominen's Q2 comparable EBITDA was clearly ahead of Vara Research consensus, supported by improving volumes and lower fixed costs. Self-help measures started to support development while the company noted an unfavourable mix and difficulties in meeting...
Following its rights issue, Suominen's strengthened balance sheet now allows the company to fully focus on executing its Full Potential turnaround program. However, there is still plenty of work ahead.
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Suominen Q2 comparable EBITDA of EUR 4.3m came 45% above Vara Research consensus expectations. Net sales of EUR 106m were up 6% y/y and came 1% below consensus. FX had EUR 1.3m negative impact on sales. EBITDA improvement was mainly related to higher...
Ahead of Suominen's Q2 results, we make minor estimate revisions and adjust for the successful rights issue. End markets were likely stable in Q2, and the company should start to benefit from easier comps and a partial recovery of previously lost volumes...
